Prestige Wealth Management Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.71K Hold
10
– – ﹤0.01% 629
2026
Q2
$3.59K Buy
10
+3
+43% +$917 ﹤0.01% 653
2026
Q1
$1.76K Sell
7
-2
-22% -$498 ﹤0.01% 766
2025
Q4
$2.48K Hold
9
– – ﹤0.01% 722
2025
Q3
$2.36K Hold
9
– – ﹤0.01% 709
2025
Q2
$1.97K Buy
+9
New +$1.92K ﹤0.01% 738
2024
Q3
– Sell
-5
Closed -$1.65K – 1051
2024
Q2
$1.65K Hold
5
– – ﹤0.01% 758
2024
Q1
$1.98K Hold
5
– – ﹤0.01% 746
2023
Q4
$1.76K Hold
5
– – ﹤0.01% 769
2023
Q3
$1.88K Hold
5
– – ﹤0.01% 755
2023
Q2
$1.91K Hold
5
– – ﹤0.01% 768
2023
Q1
$1.73K Sell
5
-6
-55% -$1.75K ﹤0.01% 773
2022
Q4
$2.59K Sell
11
-4
-27% -$948 ﹤0.01% 779
2022
Q3
$4K Buy
15
+5
+50% +$1.52K ﹤0.01% 631
2022
Q2
$3K Sell
10
-8
-44% -$2.6K ﹤0.01% 715
2022
Q1
$8K Hold
18
– – ﹤0.01% 521
2021
Q4
$8K Sell
18
-3
-14% -$1.29K ﹤0.01% 539
2021
Q3
$9K Hold
21
– – ﹤0.01% 515
2021
Q2
$8K Buy
21
+3
+17% +$991 ﹤0.01% 534
2021
Q1
$5K Buy
18
+1
+6% +$286 ﹤0.01% 639
2020
Q4
$5K Hold
17
– – ﹤0.01% 602
2020
Q3
$5K Hold
17
– – ﹤0.01% 552
2020
Q2
$4K Sell
17
-5
-23% -$982 ﹤0.01% 578
2020
Q1
$3K Buy
+22
New +$3.39K ﹤0.01% 602
2019
Q1
– Sell
-20
Closed -$2K – 1152
2018
Q4
$2K Buy
+20
New +$2.17K ﹤0.01% 894

Other funds holding WST

Prestige Wealth Management Group's WST Position: Q3 2026 in Review

Prestige Wealth Management Group held its West Pharmaceutical (WST) position steady in Q3 2026 at 10 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #629.

Prestige Wealth Management Group first reported a position in WST in Q4 2018 and has held it in 25 quarters since. The position peaked at $9K in Q3 2021. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Prestige Wealth Management Group held 10 shares of West Pharmaceutical worth $3.71K as of Q3 2026.
  • Prestige Wealth Management Group left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q3 2026, its #629 holding.
  • Prestige Wealth Management Group first reported a position in West Pharmaceutical in Q4 2018 and has held it in 25 quarters since.
  • Prestige Wealth Management Group's West Pharmaceutical position peaked at $9K in Q3 2021.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Prestige Wealth Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.